Evidence map›Paper›PMID 41387380›Full record

ArticleThe FEBS journal2026

3'UTR variants of ALS-linked RNAs modify subcellular and cellular phenotypes.

Melis Savasan-Sogut, Danae Campos-Melo, Michael J Strong

Abstract read
In one paragraph

Article in The FEBS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Melis Savasan-SogutMolecular Medicine Group, Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, Canada.
Danae Campos-MeloMolecular Medicine Group, Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, Canada.ORCID 0009-0006-2681-7790
Michael J StrongMolecular Medicine Group, Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, Canada.ORCID 0000-0003-1988-6262

Funding

CIHR SOP-160442
6 · The paper itself

Abstract

While most human genes express mRNA 3'untranslated region (3'UTR) variants of different lengths, their impact on cell physiology and disease remains largely unknown. Here, we studied 3'UTR length heterogeneity in amyotrophic lateral sclerosis (ALS) and determined that three ALS-linked transcripts exhibit lengthening of their 3'UTRs in patient samples. We investigated phenotypical effects in a neuronal cell line expressing these 3'UTRs and observed that expression of these unique 3'UTRs induces morphological changes at different levels. Among the most expressed 3'UTR variants in ALS, NEFH 3'UTR-Long induces the formation of nuclear RNA clusters, and Superoxide Dismutase 1 3'UTR-Long diminishes filopodia in the plasma membrane. Sequestosome 1 3'UTR-Long did not show major changes in nuclear RNA clusters or filopodia. Our findings provide the first evidence that 3'UTRs can modulate cellular phenotype independent of the coding region, further expanding the impact of alterations in mRNA biogenesis in ALS.

Indexed as

3' Untranslated RegionsAmyotrophic Lateral SclerosisPolyadenylationSpinal CordGenetic VariationNeurofilament ProteinsPhenotypePseudopodiaSequestosome-1 ProteinSuperoxide Dismutase-13' Untranslated Regionsneurofilament protein HNeurofilament ProteinsSequestosome-1 ProteinSOD1 protein, humanSQSTM1 protein, humanSuperoxide Dismutase-13′UTR variantsALSfilopodialamellipodiaRNA clusters

Identifiers

PMID41387380
PMCPMC13080226

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.